Topical application of drugs to stop discomfort after canulation.
Phase 3
- Conditions
- Health Condition 1: null- Any patient admitted in ICUHealth Condition 2: K80- CholelithiasisHealth Condition 3: K80- Cholelithiasis
- Registration Number
- CTRI/2017/10/010153
- Lead Sponsor
- DR AKHILESHWAR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Any patient being admitted to intensive care ward with intravenous cannula of less than 3 days or new intravenous canula has to be secured.
Exclusion Criteria
1.Patients with history of deep vein thrombosis.
2.Patients receiving steroid, antiiflammatory agents or heparin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method development of Thrombophlebitis at canula insertion siteTimepoint: 5 DAYS post intravenous canulation
- Secondary Outcome Measures
Name Time Method Any adverse effect of drug.Timepoint: 5 DAYS post intravenous canulation